# CABENUVA KIT
> **NDA212888** · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2021-01-21
## Drug
- **FDA Application Number:** NDA212888
- **Application type:** New Drug Application
- **Brand name:** CABENUVA KIT
- **Generic name:** CABOTEGRAVIR AND RILPIVIRINE
- **Active ingredients:** CABOTEGRAVIR; RILPIVIRINE
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** VIIV HLTHCARE
- **Manufacturer:** ViiV Healthcare Company
- **First approval:** 2021-01-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212888)
---
*MORVS · CC0 1.0*